BCRX
BioCryst Pharmaceuticals Inc.
$7.07
-$0.15(-2.15%)
45
Overall
40
Value
36
Tech
60
Quality
Market Cap
$1.46B
Volume
2.54M
52W Range
$6.02 - $11.31
Target Price
$16.55
EPS Estimates Overview
| Current Quarter | $0.05 | Next Quarter | $0.03 |
| Current Year | $0.1 | Next Year | $0.54 |
| QoQ Growth | -40.0% | YoY Growth | +440.0% |
| 3Y EPS CAGR | +25.3% | Target Price | $16.55 |
| Consensus | Buy | Upside | +134.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $7.07 | -2.1% | 2.54M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW